BRENDAN CARROLL: Open Payments
NPI 1861503591 · FAIRBORN, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$18,631 in 121 payments from 13 companies in 2025. Trend: 2023 $26,233 · 2024 $35,503 · 2025 $18,631
Speaker / faculty: $16,160Food & beverage: $2,246Travel & lodging: $225
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 22 | $16,782 |
| E.R. Squibb & Sons, L.L.C. | 12 | $442 |
| Vanda Pharmaceuticals Inc. | 22 | $361 |
| Neurocrine BioSciences, Inc. | 13 | $283 |
| Otsuka America Pharmaceutical, Inc. | 18 | $263 |
| ABBVIE INC. | 15 | $148 |
| Alkermes, Inc. | 5 | $101 |
| Lundbeck LLC | 6 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $47 |
| Biogen, Inc. | 2 | $37 |
Products named: UZEDY, COBENFY, INGREZZA, REXULTI, HETLIOZ, FANAPT, VRAYLAR, AUSTEDO XR.
Industry payments across OH — which companies pay providers there.
